Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
1995 4
1996 4
1997 4
1999 2
2000 3
2001 2
2002 1
2003 3
2004 4
2005 2
2006 2
2007 3
2008 7
2009 5
2010 3
2011 3
2012 5
2013 1
2014 1
2015 2
2016 2
2017 3
2018 3
2019 1
2020 6
2021 3
2022 3
Text availability
Article attribute
Article type
Publication date

Search Results

77 results
Results by year
Filters applied: . Clear all
Page 1
Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (RELIEF): a double-blind, randomised, placebo-controlled, phase 2b trial.
Behr J, Prasse A, Kreuter M, Johow J, Rabe KF, Bonella F, Bonnet R, Grohe C, Held M, Wilkens H, Hammerl P, Koschel D, Blaas S, Wirtz H, Ficker JH, Neumeister W, Schönfeld N, Claussen M, Kneidinger N, Frankenberger M, Hummler S, Kahn N, Tello S, Freise J, Welte T, Neuser P, Günther A; RELIEF investigators. Behr J, et al. Among authors: frankenberger m. Lancet Respir Med. 2021 May;9(5):476-486. doi: 10.1016/S2213-2600(20)30554-3. Epub 2021 Mar 30. Lancet Respir Med. 2021. PMID: 33798455 Clinical Trial.
Lamination of Separators to Electrodes using Electrospinning.
Springer BC, Frankenberger M, Pettinger KH. Springer BC, et al. Among authors: frankenberger m. PLoS One. 2020 Jan 28;15(1):e0227903. doi: 10.1371/journal.pone.0227903. eCollection 2020. PLoS One. 2020. PMID: 31990950 Free PMC article.
Single-cell RNA sequencing reveals ex vivo signatures of SARS-CoV-2-reactive T cells through 'reverse phenotyping'.
Fischer DS, Ansari M, Wagner KI, Jarosch S, Huang Y, Mayr CH, Strunz M, Lang NJ, D'Ippolito E, Hammel M, Mateyka L, Weber S, Wolff LS, Witter K, Fernandez IE, Leuschner G, Milger K, Frankenberger M, Nowak L, Heinig-Menhard K, Koch I, Stoleriu MG, Hilgendorff A, Behr J, Pichlmair A, Schubert B, Theis FJ, Busch DH, Schiller HB, Schober K. Fischer DS, et al. Among authors: frankenberger m. Nat Commun. 2021 Jul 26;12(1):4515. doi: 10.1038/s41467-021-24730-4. Nat Commun. 2021. PMID: 34312385 Free PMC article.
Asthma features in severe COPD: Identifying treatable traits.
Matthes S, Stadler J, Barton J, Leuschner G, Munker D, Arnold P, Villena-Hermoza H, Frankenberger M, Probst P, Koch A, Kneidinger N, Milger K, Behr J, Neurohr C. Matthes S, et al. Among authors: frankenberger m. Respir Med. 2018 Dec;145:89-94. doi: 10.1016/j.rmed.2018.10.027. Epub 2018 Oct 26. Respir Med. 2018. PMID: 30509722 Free article.
Increased Extracellular Vesicles Mediate WNT5A Signaling in Idiopathic Pulmonary Fibrosis.
Martin-Medina A, Lehmann M, Burgy O, Hermann S, Baarsma HA, Wagner DE, De Santis MM, Ciolek F, Hofer TP, Frankenberger M, Aichler M, Lindner M, Gesierich W, Guenther A, Walch A, Coughlan C, Wolters P, Lee JS, Behr J, Königshoff M. Martin-Medina A, et al. Among authors: frankenberger m. Am J Respir Crit Care Med. 2018 Dec 15;198(12):1527-1538. doi: 10.1164/rccm.201708-1580OC. Am J Respir Crit Care Med. 2018. PMID: 30044642
Variability of forced vital capacity in progressive interstitial lung disease: a prospective observational study.
Veit T, Barnikel M, Crispin A, Kneidinger N, Ceelen F, Arnold P, Munker D, Schmitzer M, Barton J, Schiopu S, Schiller HB, Frankenberger M, Milger K, Behr J, Neurohr C, Leuschner G. Veit T, et al. Among authors: frankenberger m. Respir Res. 2020 Oct 19;21(1):270. doi: 10.1186/s12931-020-01524-8. Respir Res. 2020. PMID: 33076914 Free PMC article.
77 results